ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
XOMA Royalty Corporation

XOMA Royalty Corporation (XOMA)

25.7528
-0.5472
( -2.08% )
Actualizado: 12:23:49

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
25.7528
Postura de Compra
25.50
Postura de Venta
26.00
Volume Operado de la Acción
15,844
25.60 Rango del Día 26.22
18.57 Rango de 52 semanas 35.00
Capitalización de Mercado [m]
Precio Anterior
26.30
Precio de Apertura
26.22
Última hora de negociación
12:23:49
Volumen financiero
US$ 409,869
Precio Promedio Ponderado
25.869
Volumen promedio (3 m)
28,817
Acciones en circulación
11,782,723
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-7.49
Beneficio por acción (BPA)
-3.47
turnover
4.76M
Beneficio neto
-40.83M

Acerca de XOMA Royalty Corporation

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolo... XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
XOMA Royalty Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XOMA. The last closing price for XOMA Royalty was US$26.30. Over the last year, XOMA Royalty shares have traded in a share price range of US$ 18.57 to US$ 35.00.

XOMA Royalty currently has 11,782,723 shares in issue. The market capitalisation of XOMA Royalty is US$309.89 million. XOMA Royalty has a price to earnings ratio (PE ratio) of -7.49.

XOMA Últimas noticias

XOMA Royalty Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of...

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

Seralutinib becomes XOMA Royalty’s seventh Phase 3 royalty asset, further building the late-stage pipeline beyond its six current commercial royalty assets Seralutinib is being developed and...

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities

Zevra’s MIPLYFFA™ (arimoclomol) received FDA approval and became the sixth commercial asset in XOMA Royalty’s portfolio XOMA Royalty acquired a 50 percent economic interest in TWIST Bioscience’s...

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience

XOMA Royalty has acquired 50 percent of Twist’s existing royalty and milestone economics for $15 million XOMA Royalty’s portfolio now holds over 100 assets ranging from revenue-generating...

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

MIPLYFFA™ is the first therapy approved for use in patients with NPC, a rare genetic disorder XOMA Royalty is entitled to receive a mid-single digit royalty on MIPLYFFA™ sales and up to $52.6...

XOMA Royalty Declares Quarterly Preferred Stock Dividends

 EMERYVILLE, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following...

XOMA Royalty to Present at Upcoming Investor Conferences in September

EMERYVILLE, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at...

XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities

Cash receipts totaled $22.6 million in 2Q24, inclusive of royalty income and milestones from Day One Pharmaceuticals and Rezolute Expanded the commercial royalty and milestone portfolio with the...

XOMA Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends...

XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher

EMERYVILLE, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has received an $8.1 million milestone payment from...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-1.1072-4.1221146686526.8627.6825.251526626.83116042CS
4-9.0272-25.95514663634.7834.7824.543386428.59600755CS
12-1.7772-6.4555030875427.533524.542881729.70305551CS
262.342810.007689021823.413522.72592128.58868732CS
526.502833.780779220819.253518.572223526.47816497CS
1564.402820.622014051521.353513.482993721.28833217CS
260-2.7472-9.6392982456128.546.3213.483457024.51930322CS

XOMA - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de XOMA Royalty?
El precio actual de las acciones de XOMA Royalty es US$ 25.7528
¿Cuántas acciones de XOMA Royalty están en circulación?
XOMA Royalty tiene 11,782,723 acciones en circulación
¿Cuál es la capitalización de mercado de XOMA Royalty?
La capitalización de mercado de XOMA Royalty es USD 309.89M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de XOMA Royalty?
XOMA Royalty ha negociado en un rango de US$ 18.57 a US$ 35.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de XOMA Royalty?
El ratio precio/beneficio de XOMA Royalty es -7.49
¿Cuál es el ratio de efectivo a ventas de XOMA Royalty?
El ratio de efectivo a ventas de XOMA Royalty es 64.26
¿Cuál es la moneda de reporte de XOMA Royalty?
XOMA Royalty presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de XOMA Royalty?
El último ingresos anual de XOMA Royalty es USD 4.76M
¿Cuál es el último beneficio anual de XOMA Royalty?
El último beneficio anual de XOMA Royalty es USD -40.83M
¿Cuál es la dirección registrada de XOMA Royalty?
La dirección registrada de XOMA Royalty es CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de XOMA Royalty?
La dirección del sitio web de XOMA Royalty es www.xoma.com
¿En qué sector industrial opera XOMA Royalty?
XOMA Royalty opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
NXUNXU Inc
US$ 1.6989
(597.99%)
501.66M
WATTEnergous Corporation
US$ 1.45
(252.63%)
171.38M
INTZIntrusion Inc
US$ 5.12
(137.04%)
120.09M
AERTAeries Technology Inc
US$ 2.07
(136.06%)
3.86M
SMXSMX Security Matters Public Company
US$ 0.7701
(117.79%)
255.2M
ABPAbpro Holdings Inc
US$ 2.12
(-52.78%)
1.59M
TRAWTraws Pharma Inc
US$ 8.07
(-39.87%)
958.15k
LITMSnow Lake Resources Ltd
US$ 1.16
(-27.50%)
47.54M
DOMHDominari Holdings Inc
US$ 0.8391
(-27.03%)
154.06k
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
US$ 67.89
(-23.26%)
13.31k
NXUNXU Inc
US$ 1.6989
(597.99%)
505.03M
VINCVincerx Inc
US$ 0.344
(77.32%)
313.84M
SMXSMX Security Matters Public Company
US$ 0.7701
(117.79%)
255.83M
XTIAXTI Aerospace Inc
US$ 0.03995
(1.14%)
206.47M
WATTEnergous Corporation
US$ 1.45
(252.63%)
172.12M

XOMA Discussion

Ver más
Monksdream Monksdream 4 meses hace
XOMA approaching new 52=0 week high
👍️0
Monksdream Monksdream 10 meses hace
XOMA new 52 week high
👍️0
Preciouslife1 Preciouslife1 1 año hace
DOUBLE POST PLEASE DELETE ..
👍️0
Preciouslife1 Preciouslife1 1 año hace
https://news.yahoo.com/gma/virginia-experiencing-statewide-outbreak-serious-163550888.html . . . . XOMA, USED TO BE IN TRIALS FOR THIS INDICATION ..
👍️0
ison929 ison929 2 años hace
Keeps going up ?????
👍️0
highstakes highstakes 3 años hace
Up
👍️0
Preciouslife1 Preciouslife1 4 años hace
https://abcnews.go.com/Health/antibody-therapies-cut-deaths-reduce-exposure-covid-19/story?id=75489999&cid=social_fb_abcn&fbclid=IwAR3XmMyE72XnwruiQkdXo5bW7v1o8Vu70oVSvyOgI1D4VXLHbpj1X4X0rUs
👍️0
JDUB JDUB 4 años hace
Novartis bought over half a million shares of XOMA! Wow!
👍️0
highstakes highstakes 5 años hace
Hmm sell or rocket to 43??

Xoma
👍️0
highstakes highstakes 5 años hace
Broke the average along with a solid report

Xoma
👍️0
highstakes highstakes 5 años hace
Nice up
News ?
Xoma
👍️0
highstakes highstakes 5 años hace
Whats with the gap?
Xoma
👍️0
highstakes highstakes 6 años hace
Could climb to 60 if the cancer trials go well years to come
Xoma
👍️0
highstakes highstakes 6 años hace
Wow 19 hit
Xoma
👍️0
highstakes highstakes 6 años hace
Up today xoma
👍️0
whytestocks whytestocks 6 años hace
News: $XOMA XOMA to Present at the 2019 H.C. Wainwright Global Life Sciences Conference

EMERYVILLE, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will present an update about the company’s business at the 2019 H.C. Wainwright Global Life Sciences in London, United Kingdom.  The pres...

In case you are interested https://marketwirenews.com/news-releases/xoma-to-present-at-the-2019-h-c-wainwright-global-life-sciences-conference-7938960.html
👍️0
highstakes highstakes 6 años hace
Nice xoma
👍️0
highstakes highstakes 6 años hace
Nice. Up time again ?
Xoma
👍️0
joe_techi joe_techi 6 años hace
Figured that $13 "deal" wouldn't last long
👍️0
highstakes highstakes 6 años hace
Hmmm xoma
👍️0
joe_techi joe_techi 6 años hace
Received message as a transaction in my account yesterday

"STOCK SPIN-OFF RECEIVED: XOMA CORP DEL RIGHT EXP 12/31/2088"

Anybody know what this means? Is this the right to buy at $13 per:

http://investors.xoma.com/news-releases/news-release-details/xoma-announces-commencement-rights-offering

The word "spin-off" has me confused
👍️0
highstakes highstakes 6 años hace
Wtf xoma
👍️0
highstakes highstakes 6 años hace
Wtf bumner
Xoma
👍️0
highstakes highstakes 6 años hace
Wow xoma
👍️0
highstakes highstakes 6 años hace
Boom nice up xoma
👍️0
highstakes highstakes 6 años hace
Good news
Xoma
👍️0
highstakes highstakes 6 años hace
Trading it. Must be. 16-18 range. Down.

Xoma
👍️0
highstakes highstakes 6 años hace
What gives
👍️0
highstakes highstakes 6 años hace
Ok this is killing me now.

Dang
Xoma
👍️0
highstakes highstakes 6 años hace
Wozaaa
👍️0
highstakes highstakes 7 años hace
Huge news
Awsome
Xoma
👍️0
highstakes highstakes 7 años hace
Huge news
Hope this helps

Xoma
👍️0
highstakes highstakes 7 años hace
Huge news!!
Russel
👍️0
highstakes highstakes 7 años hace
????huge news
Xoma
👍️0
highstakes highstakes 7 años hace
HUGE NEWS
CONGRATS!!!
Xoma
👍️0
my name is my name is 7 años hace
I keep looking at it and try and get excited but can’t seem to get there. if there is a move it will be quick and downside risk remains to strongly for me. best of luck i will be a spectator in this one.
👍️0
my name is my name is 7 años hace
daily looks nice but we should know by next week what the stock will do. still out for now.
👍️0
highstakes highstakes 7 años hace
News ?

Xoma
👍️0
my name is my name is 7 años hace
what a pumper
👍️0
highstakes highstakes 7 años hace
What is this news ?
👍️0
highstakes highstakes 7 años hace
Volume shows a steady rise up
Xoma
👍️0
my name is my name is 7 años hace
geeze now I really want to buy this stock
👍️0
jdlamont jdlamont 7 años hace
looks like a lot of dilution coming
👍️0
highstakes highstakes 7 años hace
Its at the red line

Xoma
👍️0
my name is my name is 7 años hace
there could still be money to be made here. full disclosure i almost bought a share today.
👍️0
highstakes highstakes 7 años hace
Market is correcting. Will be a rockey year. Look at a five year chart of the dow.

Xoma.
Long
👍️0
jdlamont jdlamont 7 años hace
bought at 22.78. this was uncalled for drop. Still volatile. One more license agreement and back uo to 30
👍️0
WovenO2 WovenO2 7 años hace
Up 7.8%. That was the highest gain on my "legit stock" watch list. Unfortunately, wasn't in it. Although scary low volume of 214,796. Looks like it made a nice steady climb.
👍️0
WovenO2 WovenO2 7 años hace
Needs to stay above 200 day. As for bottom...no idea. I'm not in at this time. Plus, no option trades.
👍️0
my name is my name is 7 años hace
chart is starting look interesting again but I wouldn't know where bottom is. any thoughts?
👍️0